Drug profile · INN
varenicline tartrate
VARENICLINE TARTRATE
varenicline tartrate (VARENICLINE TARTRATE) is a neuronal acetylcholine receptor; alpha4/beta2 agonist. Route of administration: nasal. Current US regulatory status: approved.
Drug details — varenicline tartrate
- US status
- approved
- Class
- —
- Route
- NASAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
varenicline tartrate (VARENICLINE TARTRATE) is a neuronal acetylcholine receptor; alpha4/beta2 agonist. Route of administration: nasal. Current US regulatory status: approved.
Key facts
Mechanism of action
Neuronal acetylcholine receptor; alpha4/beta2 agonist
Primary target: Neuronal acetylcholine receptor; alpha4/beta2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is varenicline tartrate?
varenicline tartrate (VARENICLINE TARTRATE) is a neuronal acetylcholine receptor; alpha4/beta2 agonist. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for varenicline tartrate?
VARENICLINE TARTRATE is a marketed brand name for varenicline tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of varenicline tartrate?
varenicline tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.